TRIM72, a novel negative feedback regulator of myogenesis, is transcriptionally activated by the synergism of MyoD (or myogenin) and MEF2

Soon Young Jung, Young-Gyu Ko

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

TRIM72 is known to be involved in the negative feedback regulation of myogenesis by targeting insulin receptor substrate-1. Here, we found that TRIM72 was more highly expressed in oxidative muscle with the higher activity of MEF2, compared to glycolytic muscle. Indeed, TRIM72 promoter contained an evolutionarily conserved MEF2 site juxtaposed to E-box. TRIM72 promoter activity was decreased by the site-directed mutagenesis of either E-boxes or a MEF2 site and synergistically enhanced by MyoD (or myogenin) and MEF2, which were associated with proximal E-box, and MEF2 site of the TRIM72 promoter, respectively. Taken together all these data, we concluded that the synergism of MyoD (or myogenin) and MEF2 is necessary for TRIM72 expression during C2C12 differentiation.

Original languageEnglish
Pages (from-to)238-245
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume396
Issue number2
DOIs
Publication statusPublished - 2010 May 28

Fingerprint

Myogenin
Muscle Development
Muscle
E-Box Elements
Feedback
Insulin Receptor Substrate Proteins
Muscles
Mutagenesis
Site-Directed Mutagenesis

Keywords

  • C2C12
  • MEF2
  • MyoD
  • Myogenin
  • TRIM72

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

@article{e61af7c13a4a4cf0bc89bade4cc235c1,
title = "TRIM72, a novel negative feedback regulator of myogenesis, is transcriptionally activated by the synergism of MyoD (or myogenin) and MEF2",
abstract = "TRIM72 is known to be involved in the negative feedback regulation of myogenesis by targeting insulin receptor substrate-1. Here, we found that TRIM72 was more highly expressed in oxidative muscle with the higher activity of MEF2, compared to glycolytic muscle. Indeed, TRIM72 promoter contained an evolutionarily conserved MEF2 site juxtaposed to E-box. TRIM72 promoter activity was decreased by the site-directed mutagenesis of either E-boxes or a MEF2 site and synergistically enhanced by MyoD (or myogenin) and MEF2, which were associated with proximal E-box, and MEF2 site of the TRIM72 promoter, respectively. Taken together all these data, we concluded that the synergism of MyoD (or myogenin) and MEF2 is necessary for TRIM72 expression during C2C12 differentiation.",
keywords = "C2C12, MEF2, MyoD, Myogenin, TRIM72",
author = "Jung, {Soon Young} and Young-Gyu Ko",
year = "2010",
month = "5",
day = "28",
doi = "10.1016/j.bbrc.2010.04.072",
language = "English",
volume = "396",
pages = "238--245",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - TRIM72, a novel negative feedback regulator of myogenesis, is transcriptionally activated by the synergism of MyoD (or myogenin) and MEF2

AU - Jung, Soon Young

AU - Ko, Young-Gyu

PY - 2010/5/28

Y1 - 2010/5/28

N2 - TRIM72 is known to be involved in the negative feedback regulation of myogenesis by targeting insulin receptor substrate-1. Here, we found that TRIM72 was more highly expressed in oxidative muscle with the higher activity of MEF2, compared to glycolytic muscle. Indeed, TRIM72 promoter contained an evolutionarily conserved MEF2 site juxtaposed to E-box. TRIM72 promoter activity was decreased by the site-directed mutagenesis of either E-boxes or a MEF2 site and synergistically enhanced by MyoD (or myogenin) and MEF2, which were associated with proximal E-box, and MEF2 site of the TRIM72 promoter, respectively. Taken together all these data, we concluded that the synergism of MyoD (or myogenin) and MEF2 is necessary for TRIM72 expression during C2C12 differentiation.

AB - TRIM72 is known to be involved in the negative feedback regulation of myogenesis by targeting insulin receptor substrate-1. Here, we found that TRIM72 was more highly expressed in oxidative muscle with the higher activity of MEF2, compared to glycolytic muscle. Indeed, TRIM72 promoter contained an evolutionarily conserved MEF2 site juxtaposed to E-box. TRIM72 promoter activity was decreased by the site-directed mutagenesis of either E-boxes or a MEF2 site and synergistically enhanced by MyoD (or myogenin) and MEF2, which were associated with proximal E-box, and MEF2 site of the TRIM72 promoter, respectively. Taken together all these data, we concluded that the synergism of MyoD (or myogenin) and MEF2 is necessary for TRIM72 expression during C2C12 differentiation.

KW - C2C12

KW - MEF2

KW - MyoD

KW - Myogenin

KW - TRIM72

UR - http://www.scopus.com/inward/record.url?scp=77952741352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952741352&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.04.072

DO - 10.1016/j.bbrc.2010.04.072

M3 - Article

VL - 396

SP - 238

EP - 245

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 2

ER -